Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Treace Medical Concepts Inc (TMCI)

Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 686,716
  • Shares Outstanding, K 61,755
  • Annual Sales, $ 187,120 K
  • Annual Income, $ -49,530 K
  • 60-Month Beta 0.37
  • Price/Sales 3.70
  • Price/Cash Flow N/A
  • Price/Book 4.92
Trade TMCI with:

Options Overview Details

View History
  • Implied Volatility 163.02% ( +95.55%)
  • Historical Volatility 274.93%
  • IV Percentile 99%
  • IV Rank 99.53%
  • IV High 163.69% on 10/09/23
  • IV Low 20.49% on 05/26/23
  • Put/Call Vol Ratio 0.52
  • Today's Volume 4,336
  • Volume Avg (30-Day) 302
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 7,818
  • Open Int (30-Day) 7,874

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.30
  • Number of Estimates 4
  • High Estimate -0.27
  • Low Estimate -0.37
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -30.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.10 +4.63%
on 05/08/24
12.74 -66.33%
on 04/09/24
-7.95 (-64.95%)
since 04/08/24
3-Month
4.10 +4.63%
on 05/08/24
15.98 -73.15%
on 02/12/24
-10.81 (-71.59%)
since 02/08/24
52-Week
4.10 +4.63%
on 05/08/24
27.70 -84.51%
on 05/23/23
-21.68 (-83.48%)
since 05/08/23

Most Recent Stories

More News
TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 4.23 (-61.96%)
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 0% and 6.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TMCI : 4.23 (-61.96%)
RWLK : 1.0501 (+6.07%)
TREACE SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 4.23 (-61.96%)
TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 4.23 (-61.96%)
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -6.78% and 1.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

PRCT : 60.90 (-3.01%)
TMCI : 4.23 (-61.96%)
TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 4.23 (-61.96%)
TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 4.23 (-61.96%)
Treace Medical Concepts (TMCI) Surges 7.6%: Is This an Indication of Further Gains?

Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the...

TMCI : 4.23 (-61.96%)
ITGR : 112.76 (-0.34%)
TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 4.23 (-61.96%)
TREACE SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 4.23 (-61.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Treace Medical Concepts Inc. is a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus. Treace Medical Concepts Inc. is based in PONTE VEDRA, Fla.

See More

Key Turning Points

3rd Resistance Point 11.51
2nd Resistance Point 11.41
1st Resistance Point 11.26
Last Price 4.23
1st Support Level 11.01
2nd Support Level 10.91
3rd Support Level 10.76

See More

52-Week High 27.70
Fibonacci 61.8% 18.68
Fibonacci 50% 15.90
Fibonacci 38.2% 13.12
Last Price 4.23
52-Week Low 4.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar